Principal Financial Group Inc Cytek Biosciences, Inc. Transaction History

Principal Financial Group Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$4.73 - $6.73 $108,922 - $154,978	23,028 Added 4.8%	503,172 $2.79 Million
Q2 2024 Jul 29, 2024	SELL	$5.3 - $6.91 $204,315 - $266,380	-38,550 Reduced 7.43%	480,144 $2.68 Million
Q1 2024 Apr 29, 2024	SELL	$6.29 - $9.15 $199,575 - $290,320	-31,729 Reduced 5.76%	518,694 $3.48 Million
Q4 2023 Feb 07, 2024	SELL	$4.1 - $9.51 $33,304 - $77,249	-8,123 Reduced 1.45%	550,423 $5.02 Million
Q3 2023 Nov 02, 2023	BUY	$5.52 - $9.5 $455,157 - $783,332	82,456 Added 17.32%	558,546 $3.08 Million
Q2 2023 Aug 07, 2023	BUY	$6.69 - $11.99 $2.9 Million - $5.19 Million	433,065 Added 1006.54%	476,090 $4.07 Million
Q1 2023 May 09, 2023	SELL	$8.44 - $13.47 $39,001 - $62,244	-4,621 Reduced 9.7%	43,025 $395,000
Q4 2022 Feb 09, 2023	BUY	$9.71 - $15.86 $15,866 - $25,915	1,634 Added 3.55%	47,646 $486,000
Q3 2022 Nov 09, 2022	SELL	$10.96 - $15.45 $574,172 - $809,394	-52,388 Reduced 53.24%	46,012 $678,000
Q2 2022 Aug 10, 2022	BUY	$7.41 - $11.56 $611,399 - $953,815	82,510 Added 519.26%	98,400 $1.06 Million
Q1 2022 May 09, 2022	BUY	$9.89 - $17.25 $157,152 - $274,102	15,890 New	15,890 $171,000

134

71.7M

400

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $870M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.